Direct block of Ca2+ channels by calmidazolium in cultured vascular smooth muscle cells

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 4, 1999, Pages 488-496

  Sunagawa, Masanori ^a,b   Yokoshiki, Hisashi ^a   Seki, Takashi ^a   Nakamura, Mariko ^a,b   Laber, Patrick ^a   Sperelakis, Nicholas ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

A7r5 cell line.; Calmidazolium; Cultured vascular smooth muscle cells; L type Ca2+ channels; Whole cell voltage clamp

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; CALCIUM CHANNEL; CALCIUM ION; CALMIDAZOLIUM; CALMODULIN; EGTAZIC ACID; PROTEIN KINASE (CALCIUM,CALMODULIN) II; CALCIUM CHANNEL BLOCKING AGENT; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CHANNEL GATING; CONCENTRATION RESPONSE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; TRANSPORT KINETICS; VASCULAR SMOOTH MUSCLE; CELL LINE; CELL MEMBRANE POTENTIAL; DRUG EFFECT; PATCH CLAMP; TIME;

CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELL LINE; EGTAZIC ACID; ENZYME INHIBITORS; IMIDAZOLES; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE INHIBITORS; TIME FACTORS;

EID: 0032589374     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199910000-00003     Document Type: Article

References (25)

1. Bkaily G, Sperelakis N. Calmodulin is required for a full activation of the calcium slow channels in heart cells. J Cyclic Nucleotide Protein Phosphor Res 1986;11:25-34.
2. Crivici A, Ikura M. Molecular and structural basis of target recognition by calmodulin. Annu Rev Biophys Biomol Struct 1995; 24:85-116.
3. Gnegy ME. Calmodulin in neurotransmitter and hormone action. Annu Rev Pharmacol Toxicol 1993;33:45-70.
4. Pronin AN, Satpaev DK, Slepak VZ, Benovic JL. Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain. J Biol Chem 1997;272:18273-80.
5. Sperelakis N. Properties of calcium channels in cardiac muscle and vascular smooth muscle. Mol Cell Biochem 1990;99:97-109.
6. Gallagher PJ, Herring BP, Stull JT. Myosin light chain kinases. J Muscle Res Cell Motil 1997;18:1-16.
7. 2+/calmodulin-dependent protein kinase II in vascular smooth muscle cells. J Biol Chem 1996;271: 2506-13.
8. Braun AP, Schulman H. The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu Rev Physiol 1995;57:417-45.
9. Yakel JL. Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol Sci 1997;18:124-34.
10. ++-transport ATPase and of calmodulin-regulated functions. Biochem Biophys Res Commun 1981;101: 418-25.
11. Klöckner U, Isenberg G. Calmodulin antagonists depress calcium and potassium currents in ventricular and vascular myocytes. Am J Physiol 1987;253:H1601-11.
12. 2+ channels in smooth muscle from rat vas deferens. Br J Pharmacol 1993;109:137-41.
13. Lorenz JN, Bielefeld DR, Sperelakis N, Regulation of calcium channel current in A7r5 vascular smooth muscle cells by cyclic nucleotides. Am J Physiol 1994;266:C1656-63.
14. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recordings from cells and cell-free membrane patch. Pflugers Arch 1981;391: 85-100.
15. 2+ channel currents by intracellular ATP in smooth muscle cells of rat mesenteric artery. Am J Physiol 1997;272:H814-9.
16. Fabiato A, Fabiato F. Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells. J Physiol (Paris) 1979;75:463-505.
17. Payne ME, Fong YL, Ono T, et al. Calcium/calmodulin-dependent protein kinase II: characterization of distinct calmodulin binding and inhibitory domains. J Biol Chem 1988;263:7190-5.
18. Pusch M, Neher E. Rates of diffusional exchange between small cells and a measuring patch pipette. Pflugers Arch 1988;411:204-11.
19. 2+ current through activation of protein kinase A in cultured vascular smooth muscle cells. J Vasc Res 1998;35:303-9.
20. 2+-channels and insulin release but has no effect on the phospholipase C system in insulin producing RINm5F-cells. Biosci Rep 1994;14:145-58.
21. 2+-channel activity in mouse pancreatic β-cells stimulated with calmidazolium (compound R24571). FEBS Lett 1995;369:315-20.
22. 2+ channel current in PC 12 cells. Eur J Pharmacol 1996;314:143-50.
23. Kusaka M, Sperelakis N. Inhibition of L-type calcium current by genistein, a tyrosine kinase inhibitor, in pregnant rat myometrial cells. Biochim Biophys Acta 1995;1240:196-200.
24. Yokoshiki K, Sumii K, Sperelakis N. Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein. J Mol Cell Cardiol 1996;28:807-14.
25. Sperelakis N, ed. Electrogenesis of biopotentials in the cardiovascular system. Norwell: Kluwer Academic Publishers, 1995.